Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

April 20, 2017

Study examines new breast cancer drug combination

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.

By VUMC News and Communications
April 13, 2017

Musician, physician collaborate to create message of hope on film

Nashville musician and producer Jesse Boyce compares the anxiety he felt just before receiving palliative radiation therapy to the jitters he often experienced before going on stage. The instant treatment began — and as the first note rang out — his anxiety was replaced by a sense of peace and determination.

By Jill Clendening
April 6, 2017

Vanderbilt’s Pietenpol joins Sledge as a Chief Scientific Advisor for Susan G. Komen

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen.

By VUMC News and Communications
April 3, 2017

Vanderbilt investigator lands Stand Up To Cancer grant for “smart” nanoparticles cancer research

John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology.
April 3, 2017

Funding opportunity: American Cancer Society-Institutional Research Grant

Applications are being sought for funding by the American Cancer Society‐Institutional Research Grant program. These funds are designed to provide seed money to support junior faculty members with an interest in cancer research who do not have external grant support.

By VUMC News and Communications
March 30, 2017

Horn to lead lung cancer combination therapy trial

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer.

By VUMC News and Communications
March 30, 2017

Research support

DS Services of America Inc. recently presented a $100,000 gift to Vanderbilt-Ingram Cancer Center (VICC) to support breast cancer research.
By VUMC News and Communications
March 30, 2017

Nanobeacon lights up colon tumors

A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening.
By Bill Snyder
March 24, 2017

VUMC to offer free head and neck cancer screening April 7

A hoarse voice or persistent sore throat that lasts for weeks may seem like a mild nuisance, but those same symptoms could be early signs of head and neck cancer. To help patients determine their risk for disease and detect problems at an early stage, the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 7, from 9 a.m. to 3 p.m.
By VUMC News and Communications
March 23, 2017

Annual Meharry–Vanderbilt–TSU Cancer Partnership retreat April 8

The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8.
By VUMC News and Communications
March 23, 2017

Breast cancer program lands new research grants

Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients.
By VUMC News and Communications
March 14, 2017

VICC ovarian cancer funding opportunity

The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to catalyze innovative, collaborative ovarian cancer-related projects.
By VUMC News and Communications
March 2, 2017

Investigators seek new way to define cell identity

Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types.
By Leigh MacMillan
1 … 31 32 33 34 35 … 58